AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
Log in

NASDAQ:ONTXOnconova Therapeutics SEC Filings & 10K Form

$0.58
-0.01 (-1.70 %)
(As of 07/8/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.57
Now: $0.58
$0.59
50-Day Range
$0.36
MA: $0.51
$0.61
52-Week Range
$0.10
Now: $0.58
$2.87
Volume3.14 million shs
Average Volume13.39 million shs
Market Capitalization$97.40 million
P/E RatioN/A
Dividend YieldN/A
Beta2.18

SEC Filings

Onconova Therapeutics (NASDAQ:ONTX) SEC Filings

DateFilerForm TypeView
06/12/2020
4:18 PM
Onconova Therapeutics (Filer)
Form DEFA14A
06/10/2020
4:28 PM
Onconova Therapeutics (Filer)
Form DEFA14A
06/10/2020
4:27 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2020
3:18 PM
Onconova Therapeutics (Issuer)
Shoemaker Mary Teresa (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/02/2020
4:29 PM
Onconova Therapeutics (Filer)
Form DEFA14A
06/02/2020
4:25 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2020
4:10 PM
GROOPMAN JEROME (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
8:19 AM
OLER ABRAHAM N. (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
8:09 AM
Guerin Mark Patrick (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
8:07 AM
Fruchtman Steven M (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
11:15 PM
Onconova Therapeutics (Filer)
Form EFFECT
05/15/2020
3:47 PM
Onconova Therapeutics (Filer)
Form S-3/A
05/15/2020
3:11 PM
Onconova Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
6:56 AM
Onconova Therapeutics (Filer)
Form DEFA14A
05/11/2020
6:55 AM
Onconova Therapeutics (Filer)
Form DEFA14A
04/24/2020
4:28 PM
Onconova Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/09/2020
4:20 PM
Onconova Therapeutics (Filer)
Form PRE 14A
02/14/2020
3:53 PM
Onconova Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
01/23/2020
7:38 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2020
4:26 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
3:06 PM
Onconova Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
01/10/2020
3:03 PM
ARMISTICE CAPITAL, LLC (Filed by)
Onconova Therapeutics (Subject)
Form SC 13G
01/03/2020
4:29 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2020
8:28 AM
Onconova Therapeutics (Filer)
Form 424B5
12/26/2019
8:11 AM
Onconova Therapeutics (Issuer)
Woodman Richard Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
8:08 AM
OLER ABRAHAM N. (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
8:07 AM
Fruchtman Steven M (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
8:06 AM
Guerin Mark Patrick (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
8:05 AM
Maniar Manoj (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2019
3:50 PM
ARMISTICE CAPITAL, LLC (Filed by)
Onconova Therapeutics (Subject)
Form SC 13G
12/19/2019
3:16 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
8:22 AM
Onconova Therapeutics (Filer)
Form 424B5
12/19/2019
8:19 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
8:07 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
10:19 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
7:02 AM
Onconova Therapeutics (Filer)
Form 424B5
12/09/2019
8:07 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
3:04 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2019
4:12 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Onconova Therapeutics (Subject)
Form SC 13G
11/27/2019
7:33 AM
MEHTA VIREN (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
4:24 PM
Onconova Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
11/26/2019
6:57 AM
Onconova Therapeutics (Issuer)
Reddy E Premkumar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
6:53 AM
MARINO JAMES J (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
6:51 AM
Fruchtman Steven M (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
6:50 AM
Guerin Mark Patrick (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
6:46 AM
OLER ABRAHAM N. (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
6:00 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2019
7:56 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2019
7:54 AM
Onconova Therapeutics (Filer)
Form 424B4
11/21/2019
11:15 PM
Onconova Therapeutics (Filer)
Form EFFECT
11/21/2019
7:15 AM
Onconova Therapeutics (Filer)
Form S-1/A
11/21/2019
6:45 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
4:16 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
3:05 PM
Onconova Therapeutics (Subject)
TYNDALL CAPITAL PARTNERS L P (Filed by)
Form SC 13G/A
11/12/2019
4:30 PM
Onconova Therapeutics (Filer)
Form S-1/A
11/12/2019
4:10 PM
Onconova Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2019
8:59 PM
Onconova Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/24/2019
6:44 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
5:22 PM
MARINO JAMES J (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2019
3:16 PM
Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2019
4:41 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2019
4:31 PM
Armistice Capital Master Fund Ltd. (Reporting)
ARMISTICE CAPITAL, LLC (Reporting)
Boyd Steven (Reporting)
Onconova Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/25/2019
5:40 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2019
5:32 AM
Onconova Therapeutics (Filer)
Form 424B3
09/25/2019
5:28 AM
Onconova Therapeutics (Filer)
Form 424B3
09/25/2019
5:25 AM
Onconova Therapeutics (Filer)
Form 424B5
09/24/2019
3:08 PM
Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
3:05 PM
Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
2:21 PM
683 Capital Management, LLC (Reporting)
683 Capital Partners, LP (Reporting)
Onconova Therapeutics (Issuer)
Zweiman Ari (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2019
2:20 PM
683 Capital Management, LLC (Filed by)
Onconova Therapeutics (Subject)
Form SC 13D/A
09/17/2019
4:26 PM
Onconova Therapeutics (Filer)
Form 424B5
09/13/2019
4:29 PM
Onconova Therapeutics (Subject)
Form FWP
09/13/2019
3:24 PM
Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2019
2:51 PM
Onconova Therapeutics (Filer)
Form 424B5
09/13/2019
2:47 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
3:16 PM
Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:10 PM
Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
3:46 PM
Onconova Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/14/2019
4:22 PM
Onconova Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2019
6:48 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
4:27 PM
GROOPMAN JEROME (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
4:26 PM
Hoffman Michael B (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
4:25 PM
MARINO JAMES J (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
4:24 PM
MEHTA VIREN (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
4:23 PM
Onconova Therapeutics (Issuer)
Reddy E Premkumar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
4:21 PM
Onconova Therapeutics (Issuer)
STOVER JACK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2019
3:47 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2019
3:43 PM
Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
3:35 PM
Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:21 PM
Onconova Therapeutics (Issuer)
TYNDALL CAPITAL PARTNERS L P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:05 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
7:38 PM
Onconova Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
05/24/2019
4:15 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2019
11:15 PM
Onconova Therapeutics (Filer)
Form EFFECT
05/17/2019
4:13 PM
Onconova Therapeutics (Filer)
Form S-3/A
05/17/2019
3:37 PM
Onconova Therapeutics (Filer)
Form 424B2
05/16/2019
3:04 PM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
7:15 AM
Onconova Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
3:45 PM
Onconova Therapeutics (Filer)
Form DEF 14A
04/08/2019
6:19 PM
Maniar Manoj (Reporting)
Onconova Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.